MRUS - Merus N.V.
90
-6.920 -7.689%
Share volume: 2,728,675
Last Updated: 12-29-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$96.92
-6.92
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-01-2024 | 10-31-2024 | 02-27-2025 | 05-07-2025 | 08-05-2025 | 10-31-2025 | |
| Assets | ||||||||
| Total Assets | 498.083 M | 892.228 M | 844.676 M | 782.693 M | 730.922 M | 980.176 M | 904.196 M | |
| Current Assets | 410.260 M | 806.553 M | 666.276 M | 569.072 M | 522.272 M | 768.282 M | 691.929 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 159.328 M | 157.948 M | 199.270 M | 243.733 M | 261.126 M | 267.433 M | 268.441 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 178.168 M | 629.475 M | 432.998 M | 293.294 M | 197.199 M | 442.791 M | 367.491 M | |
| Total Non-current Assets | 61.167 M | 58.961 M | 150.620 M | 187.008 M | 183.335 M | 184.159 M | 182.908 M | |
| Property Plant Equipment | 11.336 M | 12.090 M | 12.146 M | 10.770 M | 10.937 M | 11.346 M | 11.353 M | |
| Other Assets | 76.487 M | 73.585 M | 166.254 M | 202.851 M | 197.713 M | 200.548 M | 200.914 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 498.083 M | 892.228 M | 844.676 M | 782.693 M | 730.922 M | 980.176 M | 904.196 M | |
| Total liabilities | 148.635 M | 145.456 M | 141.415 M | 134.766 M | 134.803 M | 138.440 M | 129.264 M | |
| Total current liabilities | 78.487 M | 80.864 M | 80.076 M | 87.076 M | 89.130 M | 91.579 M | 86.800 M | |
| Accounts Payable | 7.488 M | 4.395 M | 6.185 M | 4.164 M | 8.984 M | 21.075 M | 8.392 M | |
| Other liabilities | 9.853 M | 9.332 M | 9.284 M | 8.208 M | 8.084 M | 8.754 M | 9.555 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 9.853 M | 9.332 M | 9.284 M | 8.208 M | 8.084 M | 8.754 M | 9.555 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 349.448 M | 746.772 M | 703.261 M | 647.927 M | 596.119 M | 841.736 M | 774.932 M | |
| Common stock | 1.167 B | 1.623 B | 1.648 B | 1.672 B | 1.693 B | 2.046 B | 2.074 B | |
| Retained earnings | -787.517 M | -837.559 M | -937.464 M | -968.387 M | -1.065 B | -1.223 B | -1.319 B |